Researchers have identified a method to enhance the effectiveness of a promising cancer treatment. They found that modifying ...
Gene editing promised a revolution, but biotech layoffs, stock slumps, and industry struggles reveal a stark reality: CRISPR ...
Sangamo (SGMO) reported positive updated data from a Phase 1/2 study of its gene therapy candidate ST-920 in the treatment of Fabry disease. Read more here.
With the addition of Casgevy, Children’s Hospital Los Angeles now offers two gene therapies for sickle cell, the first being Lyfgenia.
Exagamglogene autotemcel (exa-cel) gene therapy offers a potential cure for severe sickle cell disease, now available on NHS.
New gene therapies could transform sickle cell treatment forever. A future without pain crises or hospitalizations may finally be within reach.
3d
The Punch on MSNGroundbreaking sickle cell disease treatment approved for English NHSSickle cell anaemia is a genetic blood disorder characterised by the production of an abnormal haemoglobin, known as haemoglobin S. Sickle cell disease changes the shape of blood cells into a crescent ...
A new gene editing treatment has been approved for use in the NHS, which will help treat sickle cell disease patients ...
Researchers are enhancing the best features of AAV capsids and overcoming their limitations to accelerate gene-based therapies.
Healthcare analyst Ellen Andrews, Ph.D, says we are lucky to live in a time when creative scientists are developing life-changing new treatments such as gene therapies offering cures for debilitating ...
The gene-editing treatment will be available to certain patients with sickle cell disease in England as Vertex commits to collecting additional data.
President Trump signed an executive order on the day of his inauguration that created doubts about the future of a program ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results